Lasse Beijer
CIK 1408215 · View on SEC EDGAR ↗
First SEC filing: Aug. 1, 2007 · Latest: Aug. 1, 2007
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Aug. 26, 2008 | RMD | S | 366 | $44.93 | $16,444 | 0 Direct | -100.00% | Disposed | 925.4% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Nov. 7, 2007 | RMD | ResMed Common Stock Options | ResMed Common Stock (5,000) | $42.05 | Nov. 6, 2014 | 5,000 | Acquired |
| Aug. 1, 2007 | RMD | ResMed Stock Options | ResMed Common Stock (36,000) | $43.42 | July 31, 2015 | 36,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 7 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Aug. 1, 2007 | RMD | ResMed Common Stock | 146 | Direct |
| Aug. 1, 2007 | RMD | ResMed Common Stock | 12 | Indirect |
| Aug. 1, 2007 | RMD | ResMed Stock Options→ ResMed Common Stock (5,332) | 5,332 | Direct |
| Aug. 1, 2007 | RMD | ResMed Stock Options→ ResMed Common Stock (10,500) | 10,500 | Direct |
| Aug. 1, 2007 | RMD | ResMed Stock Options→ ResMed Common Stock (14,000) | 14,000 | Direct |
| Aug. 1, 2007 | RMD | ResMed Stock Options→ ResMed Common Stock (400) | 400 | Indirect |
| Aug. 1, 2007 | RMD | ResMed Stock Options→ ResMed Common Stock (300) | 300 | Indirect |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2008 | $279,862 | $93,120 | — | — | $172,986 | — | $82,848 | $859,679 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.